{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:30:43Z","timestamp":1787009443512,"version":"build-2736575974"},"reference-count":65,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Typhoid fever is a significant global health problem that impacts people living in areas without access to clean water and sanitation. However, collaborative international partnerships and new research have improved both knowledge of the burden in countries with endemic disease and the tools for improved surveillance, including environmental surveillance. Two typhoid conjugate vaccines (TCVs) have achieved World Health Organization prequalification, with several more in the development pipeline. Despite hurdles posed by the coronavirus disease 2019 pandemic, multiple TCV efficacy trials have been conducted in high-burden countries, and data indicate that TCVs provide a high degree of protection from typhoid fever, are safe to use in young children, provide lasting protection, and have the potential to combat typhoid antimicrobial resistance. Now is the time to double down on typhoid control and elimination by sustaining progress made through water, sanitation, and hygiene improvements and accelerating TCV introduction in high-burden locations.<\/jats:p>","DOI":"10.1093\/ofid\/ofad055","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T17:32:09Z","timestamp":1685727129000},"page":"S74-S81","source":"Crossref","is-referenced-by-count":24,"title":["Taking on Typhoid: Eliminating Typhoid Fever as a Global Health Problem"],"prefix":"10.1093","volume":"10","author":[{"given":"Jessie","family":"Chen","sequence":"first","affiliation":[{"name":"Enteric and Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6447-8586","authenticated-orcid":false,"given":"Jessica E","family":"Long","sequence":"additional","affiliation":[{"name":"Enteric and Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Vannice","sequence":"additional","affiliation":[{"name":"Enteric and Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Shewchuk","sequence":"additional","affiliation":[{"name":"Enteric and Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriya","family":"Kumar","sequence":"additional","affiliation":[{"name":"Enteric and Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Duncan Steele","sequence":"additional","affiliation":[{"name":"Enteric and Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita K M","family":"Zaidi","sequence":"additional","affiliation":[{"name":"Enteric and Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"key":"2023060210572869000_ofad055-B1","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"GBD Collaborators","year":"2020","journal-title":"Lancet"},{"key":"2023060210572869000_ofad055-B2","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1093\/cid\/ciy1094","article-title":"Global typhoid fever incidence: a systematic review and meta-analysis","volume":"68","author":"Marchello","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023060210572869000_ofad055-B3","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1093\/cid\/ciy1118","article-title":"Accelerating typhoid conjugate vaccine introduction: what can be learned from prior new vaccine introduction initiatives?","volume":"68","author":"Jamka","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023060210572869000_ofad055-B4","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1093\/cid\/ciy1117","article-title":"The coalition against typhoid: mobilizing a community for a global fight","volume":"68","author":"Lindsay","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023060210572869000_ofad055-B5","first-page":"153","article-title":"Typhoid vaccines: WHO position paper\u2014March 2018","volume":"93","author":"World Health Organization","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"2023060210572869000_ofad055-B6","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1093\/cid\/ciaa342","article-title":"Gavi support for typhoid conjugate vaccines: moving from global investments to country introduction","volume":"71","author":"Soble","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023060210572869000_ofad055-B7","author":"WHO, UNICEF","year":"2022"},{"key":"2023060210572869000_ofad055-B8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/d41586-022-02051-w","article-title":"Pandemic drives largest drop in childhood vaccinations in 30 years","volume":"608","author":"Guglielmi","year":"2022","journal-title":"Nature"},{"key":"2023060210572869000_ofad055-B9","author":"Walldorf","year":"2022"},{"key":"2023060210572869000_ofad055-B10","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull World Health Organ"},{"key":"2023060210572869000_ofad055-B11","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1093\/cid\/ciaa367","article-title":"The Surveillance for Enteric Fever in Asia Project (SEAP), Severe Typhoid Fever Surveillance in Africa (SETA), Surveillance of Enteric Fever in India (SEFI), and Strategic Typhoid Alliance Across Africa and Asia (STRATAA) population-based enteric fever studies: a review of methodological similarities and differences","volume":"71","author":"Carey","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023060210572869000_ofad055-B12","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S2214-109X(17)30022-0","article-title":"Incidence of invasive Salmonella disease in Sub-Saharan Africa: a multicentre population-based surveillance study","volume":"5","author":"Marks","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2023060210572869000_ofad055-B13","doi-asserted-by":"crossref","first-page":"S422","DOI":"10.1093\/cid\/ciz715","article-title":"The Severe Typhoid Fever in Africa program: study design and methodology to assess disease severity, host immunity, and carriage associated with invasive salmonellosis","volume":"69","author":"Park","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023060210572869000_ofad055-B14","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.4292849","article-title":"The severe typhoid in Africa program: incidences of typhoid fever in Burkina Faso, Democratic Republic of Congo, Ethiopia, Ghana, Madagascar, and Nigeria","author":"Marks","year":"2022","journal-title":"SSRN J"},{"key":"2023060210572869000_ofad055-B15","doi-asserted-by":"crossref","first-page":"e978","DOI":"10.1016\/S2214-109X(22)00119-X","article-title":"Incidence of typhoid and paratyphoid fever in Bangladesh, Nepal, and Pakistan: results of the Surveillance for Enteric Fever in Asia project","volume":"10","author":"Garrett","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2023060210572869000_ofad055-B16","doi-asserted-by":"crossref","first-page":"e1688","DOI":"10.1016\/S2214-109X(21)00370-3","article-title":"Burden of enteric fever at three urban sites in Africa and Asia: a multicentre population-based study","volume":"9","author":"Meiring","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2023060210572869000_ofad055-B17","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1002\/sim.9159","article-title":"A Bayesian approach for estimating typhoid fever incidence from large-scale facility-based passive surveillance data","volume":"40","author":"Phillips","year":"2021","journal-title":"Stat Med"},{"key":"2023060210572869000_ofad055-B18","doi-asserted-by":"crossref","first-page":"e0007805","DOI":"10.1371\/journal.pntd.0007805","article-title":"Under-detection of blood culture-positive enteric fever cases: the impact of missing data and methods for adjusting incidence estimates","volume":"14","author":"Voysey","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"2023060210572869000_ofad055-B19","author":"Uzzell","year":"2023, 8"},{"key":"2023060210572869000_ofad055-B20","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.vaccine.2019.12.061","article-title":"Cost-effectiveness of using environmental surveillance to target the roll-out typhoid conjugate vaccine","volume":"38","author":"Hagedorn","year":"2020","journal-title":"Vaccine"},{"key":"2023060210572869000_ofad055-B21","doi-asserted-by":"crossref","first-page":"e0001377","DOI":"10.1371\/journal.pgph.0001377","article-title":"Cost of wastewater-based environmental surveillance for SARS-CoV-2: evidence from pilot sites in Blantyre, Malawi and Kathmandu, Nepal","volume":"2","author":"Ngwira","year":"2022","journal-title":"PLOS Glob Public Health"},{"key":"2023060210572869000_ofad055-B22","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.15585\/mmwr.mm7133e2","article-title":"Public health response to a case of paralytic poliomyelitis in an unvaccinated person and detection of poliovirus in wastewater\u2014New York, June-August 2022","volume":"71","author":"Link-Gelles","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023060210572869000_ofad055-B23","doi-asserted-by":"crossref","first-page":"E10625","DOI":"10.1073\/pnas.1808798115","article-title":"Epidemiology of the silent polio outbreak in Rahat, Israel, based on modeling of environmental surveillance data","volume":"115","author":"Brouwer","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023060210572869000_ofad055-B24","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.3201\/eid2411.180050","article-title":"Effect of inactivated poliovirus vaccine campaigns, Pakistan, 2014\u20132017","volume":"24","author":"Grassly","year":"2018","journal-title":"Emerging Infect Dis"},{"key":"2023060210572869000_ofad055-B25","volume-title":"Environmental Surveillance for SARS-COV-2 to Complement Public Health Surveillance\u2014Interim Guidance","author":"World Health Organization","year":"2022"},{"key":"2023060210572869000_ofad055-B26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1126\/science.ade2503","article-title":"Wastewater surveillance for public health","volume":"379","author":"Levy","year":"2023","journal-title":"Science"},{"key":"2023060210572869000_ofad055-B27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41586-022-05049-6","article-title":"Wastewater sequencing reveals early cryptic SARS-CoV-2 variant transmission","volume":"609","author":"Karthikeyan","year":"2022","journal-title":"Nature"},{"key":"2023060210572869000_ofad055-B28","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.1016\/S2666-5247(22)00114-8","article-title":"Estimating typhoid incidence from community-based serosurveys: a multicohort study","volume":"3","author":"Aiemjoy","year":"2022","journal-title":"Lancet Microbe"},{"key":"2023060210572869000_ofad055-B29","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.3201\/eid2811.220239","article-title":"Seroincidence of enteric fever, Juba, South Sudan","volume":"28","author":"Aiemjoy","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"2023060210572869000_ofad055-B30","author":"Aiemjoy"},{"key":"2023060210572869000_ofad055-B31","author":"Global Polio Eradication Initiative","year":"2022"},{"key":"2023060210572869000_ofad055-B32","author":"Expanded Programme on Immunization (EPI) of the Department of Immunization, Vaccines and Biologicals","year":"2015"},{"key":"2023060210572869000_ofad055-B33","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"key":"2023060210572869000_ofad055-B34","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1905047","article-title":"Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in nepal","volume":"381","author":"Shakya","year":"2019","journal-title":"N Engl J Med"},{"key":"2023060210572869000_ofad055-B35","doi-asserted-by":"crossref","first-page":"e1561","DOI":"10.1016\/S2214-109X(21)00346-6","article-title":"Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial","volume":"9","author":"Shakya","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2023060210572869000_ofad055-B36","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa2035916","article-title":"Safety and efficacy of a typhoid conjugate vaccine in Malawian children","volume":"385","author":"Patel","year":"2021","journal-title":"N Engl J Med"},{"key":"2023060210572869000_ofad055-B37","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(21)01124-7","article-title":"Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial","volume":"398","author":"Qadri","year":"2021","journal-title":"Lancet"},{"key":"2023060210572869000_ofad055-B38","author":"Date"},{"key":"2023060210572869000_ofad055-B39","doi-asserted-by":"crossref","first-page":"e1154","DOI":"10.1016\/S2214-109X(21)00255-2","article-title":"Effectiveness of typhoid conjugate vaccine against culture-confirmed Salmonella enterica serotype Typhi in an extensively drug-resistant outbreak setting of Hyderabad, Pakistan: a cohort study","volume":"9","author":"Yousafzai","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2023060210572869000_ofad055-B40","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1016\/j.vaccine.2021.08.051","article-title":"Effectiveness of typhoid conjugate vaccine against culture-confirmed typhoid in a peri-urban setting in Karachi: a case-control study","volume":"39","author":"Batool","year":"2021","journal-title":"Vaccine"},{"key":"2023060210572869000_ofad055-B41","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ijid.2021.05.061","article-title":"Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: a randomized controlled phase 2 trial","volume":"108","author":"Sirima","year":"2021","journal-title":"Int J Infect Dis"},{"key":"2023060210572869000_ofad055-B42","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijid.2020.10.103","article-title":"Safety and immunogenicity of co-administration of meningococcal type A and measles-rubella vaccines with typhoid conjugate vaccine in children aged 15\u201323 months in Burkina Faso","volume":"102","author":"Sirima","year":"2021","journal-title":"Int J Infect Dis"},{"key":"2023060210572869000_ofad055-B43","author":"Patel","year":"2022"},{"key":"2023060210572869000_ofad055-B44","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1016\/j.vaccine.2021.07.073","article-title":"Persisting antibody responses to Vi polysaccharide-tetanus toxoid conjugate (Typbar TCV\u00ae) vaccine up to 7 years following primary vaccination of children &lt;2 years of age with, or without, a booster vaccination","volume":"39","author":"Vadrevu","year":"2021","journal-title":"Vaccine"},{"key":"2023060210572869000_ofad055-B45","author":"Typhoid vaccines"},{"key":"2023060210572869000_ofad055-B46","doi-asserted-by":"crossref","first-page":"2043103","DOI":"10.1080\/21645515.2022.2043103","article-title":"A multicenter, single-blind, randomized, phase-2\/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator","volume":"18","author":"Thuluva","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"2023060210572869000_ofad055-B47","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1473-3099(21)00455-2","article-title":"Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial","volume":"22","author":"Rai G","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2023060210572869000_ofad055-B48","author":"Muhib","year":"2019"},{"key":"2023060210572869000_ofad055-B49","author":"Sikorski","year":"2021"},{"key":"2023060210572869000_ofad055-B50","author":"Clarke","year":"2021"},{"key":"2023060210572869000_ofad055-B51","volume-title":"Zim earns another WHO praise","author":"Chingwere","year":"2021"},{"key":"2023060210572869000_ofad055-B52","author":"Gavi, the Vaccine Alliance","year":"2022"},{"key":"2023060210572869000_ofad055-B53","author":"Dhawan"},{"key":"2023060210572869000_ofad055-B54","author":"International Vaccine Access Center"},{"key":"2023060210572869000_ofad055-B55","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/vaccines9030281","article-title":"Evaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana (TyVEGHA) using a cluster-randomized controlled phase IV trial: trial design and population baseline characteristics","volume":"9","author":"Haselbeck","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"2023060210572869000_ofad055-B56","doi-asserted-by":"crossref","first-page":"S788","DOI":"10.1093\/infdis\/jiab443","article-title":"Typhoid conjugate vaccine: an urgent tool to combat typhoid and tackle antimicrobial resistance","volume":"224","author":"Saha","year":"2021","journal-title":"J Infect Dis"},{"key":"2023060210572869000_ofad055-B57","first-page":"377","article-title":"Cost of illness due to typhoid fever in Pemba, Zanzibar, East Africa","volume":"32","author":"Riewpaiboon","year":"2014","journal-title":"J Health Popul Nutr"},{"key":"2023060210572869000_ofad055-B58","doi-asserted-by":"crossref","first-page":"e0277419","DOI":"10.1371\/journal.pone.0277419","article-title":"Estimating the economic burden of typhoid in children and adults in Blantyre, Malawi: a costing cohort study","volume":"17","author":"Limani","year":"2022","journal-title":"PLoS One"},{"key":"2023060210572869000_ofad055-B59","volume-title":"Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: An Action Framework","author":"WHO","year":"2020"},{"key":"2023060210572869000_ofad055-B60","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1473-3099(21)00627-7","article-title":"Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study","volume":"22","author":"Birger","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2023060210572869000_ofad055-B61","first-page":"261","article-title":"Meeting of the Strategic Advisory Group of Experts on Immunization, April 2022: conclusions and recommendations","volume":"97","author":"World Health Organization","year":"2022","journal-title":"Wkly Epidemiol Rec"},{"key":"2023060210572869000_ofad055-B62","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1007\/s00268-020-05567-2","article-title":"Morbidity and mortality of typhoid intestinal perforation among children in Sub-Saharan Africa 1995\u20132019: a scoping review","volume":"44","author":"Birkhold","year":"2020","journal-title":"World J Surg"},{"key":"2023060210572869000_ofad055-B63","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad022","article-title":"Using typhoid conjugate vaccines to prevent disease, promote health equity, and counter drug-resistant typhoid fever","author":"Nampota-Nkomba","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2023060210572869000_ofad055-B64","doi-asserted-by":"crossref","first-page":"e0010178","DOI":"10.1371\/journal.pntd.0010178","article-title":"Whole genome sequence analysis of Salmonella Typhi provides evidence of phylogenetic linkage between cases of typhoid fever in Santiago, Chile in the 1980s and 2010\u20132016","volume":"16","author":"Maes","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"2023060210572869000_ofad055-B65","doi-asserted-by":"crossref","first-page":"e0024922","DOI":"10.1128\/spectrum.00249-22","article-title":"Detection of Salmonella Typhi in bile by quantitative real-time PCR","volume":"10","author":"Higginson","year":"2022","journal-title":"Microbiol Spectr"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/Supplement_1\/S74\/50508700\/ofad055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/Supplement_1\/S74\/50508700\/ofad055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T11:42:42Z","timestamp":1702554162000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/10\/Supplement_1\/S74\/7188906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":65,"journal-issue":{"issue":"Supplement_1","published-print":{"date-parts":[[2023,6,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofad055","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,5]]},"published":{"date-parts":[[2023,5]]}}}